Navigation Links
LCA-Vision Reports 2011 Second Quarter Procedure Volume
Date:7/6/2011

CINCINNATI, July 6, 2011 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 14,081 procedures were performed during the second quarter of 2011, compared with 15,266 procedures (62 vision centers) during the second quarter of 2010.  Same-store procedures (53 vision centers) increased slightly year-over-year from 13,943 procedures during the second quarter of 2010, the third consecutive quarter of year-over-year same-store procedure growth.

LCA-Vision will release second quarter 2011 financial results prior to market opening on Tuesday, July 26, 2011.  A conference call and webcast to discuss the results also will be held on Tuesday, July 26, 2011 at 10:00 a.m. Eastern Time.

To access the conference call, dial 866-322-1352 (within the United States and Canada), or 706-643-6246 (international callers).  The webcast will be available at the investor relations section of LCA-Vision's website.  A replay of the call and webcast will begin approximately two hours after the live call has ended.  To access the replay, dial 800-642-1687 (within the United States and Canada), or 706-645-9291 (international callers) and enter the conference ID number: 78217237.

About LCA-Vision Inc./LasikPlus®LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States.  Additional company information is available at www.lca-vision.com and www.lasikplus.com. Earning Trust Every Moment;Building Relationships for a Lifetime.For Additional InformationCompany Contact:Investor Relations Contact:Barb Kise

Jody CainLCA-Vision Inc.

Lippert/Heilshorn & Associates513-792-9292

310-691-7100
'/>"/>

SOURCE LCA-Vision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes
2. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
3. BioDrain Medical, Inc. Reports Results of Annual Meeting
4. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
5. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
6. Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales
7. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
8. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9. Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance
10. China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
11. Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 ... expected to reach a value of USD 4.5 billion ... View Research, Inc. Proper closure of injured tissues post ... and function. Postoperative leakages occur in 3% to 15% ... They are responsible for one third of postoperative deaths ...
(Date:3/27/2017)... , March 27, 2017 ... to better understand Bayer and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/27/2017)... 2017  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or ... shares of common stock in an underwritten public offering ... the Securities and Exchange Commission (the "SEC"). The offering ... can be no assurance as to whether or when ... actual size or terms of the offering. Cryoport also ...
Breaking Medicine Technology:
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... ... for and by physicians, announced today the launch of a free, public-facing tool ... Via Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, ...
(Date:3/28/2017)... ... , ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; ... scientists will speak to the press on behalf of over 200 doctors, scientists, and ... safety commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street ...
(Date:3/28/2017)... Switzerland (PRWEB) , ... March 28, 2017 , ... ... for laboratory instruments are critical to ensuring high-quality results and maintaining GMP and ... Qualification of Laboratory Instruments in accordance with GMP requirements " these requirements are ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
Breaking Medicine News(10 mins):